Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2005

Open Access 01-12-2005 | Case report

Dynamic 3D echocardiography in virtual reality

Authors: Annemien E van den Bosch, Anton HJ Koning, Folkert J Meijboom, Jackie S McGhie, Maarten L Simoons, Peter J van der Spek, Ad JJC Bogers

Published in: Cardiovascular Ultrasound | Issue 1/2005

Login to get access

Abstract

Background

This pilot study was performed to evaluate whether virtual reality is applicable for three-dimensional echocardiography and if three-dimensional echocardiographic 'holograms' have the potential to become a clinically useful tool.

Methods

Three-dimensional echocardiographic data sets from 2 normal subjects and from 4 patients with a mitral valve pathological condition were included in the study. The three-dimensional data sets were acquired with the Philips Sonos 7500 echo-system and transferred to the BARCO (Barco N.V., Kortrijk, Belgium) I-space. Ten independent observers assessed the 6 three-dimensional data sets with and without mitral valve pathology. After 10 minutes' instruction in the I-Space, all of the observers could use the virtual pointer that is necessary to create cut planes in the hologram.

Results

The 10 independent observers correctly assessed the normal and pathological mitral valve in the holograms (analysis time approximately 10 minutes).

Conclusion

this report shows that dynamic holographic imaging of three-dimensional echocardiographic data is feasible. However, the applicability and use-fullness of this technology in clinical practice is still limited.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bruining N, Roelandt JR, Grunst G, Berlage T, Waldinger J, Mumm B: Three-Dimensional Echocardiography: The Gateway to Virtual Reality!. Echocardiography. 1999, 16: 417-423.CrossRefPubMed Bruining N, Roelandt JR, Grunst G, Berlage T, Waldinger J, Mumm B: Three-Dimensional Echocardiography: The Gateway to Virtual Reality!. Echocardiography. 1999, 16: 417-423.CrossRefPubMed
2.
go back to reference Bruining N, Lancee C, Roelandt JR, Bom N: Three-dimensional echocardiography paves the way toward virtual reality. Ultrasound Med Biol. 2000, 26: 1065-1074. 10.1016/S0301-5629(00)00256-8.CrossRefPubMed Bruining N, Lancee C, Roelandt JR, Bom N: Three-dimensional echocardiography paves the way toward virtual reality. Ultrasound Med Biol. 2000, 26: 1065-1074. 10.1016/S0301-5629(00)00256-8.CrossRefPubMed
3.
go back to reference Agati L: Three-dimensional echocardiography: the virtual reality in cardiology – luxury or useful technique?. Eur Heart J. 1996, 17: 487-489.CrossRefPubMed Agati L: Three-dimensional echocardiography: the virtual reality in cardiology – luxury or useful technique?. Eur Heart J. 1996, 17: 487-489.CrossRefPubMed
4.
go back to reference Gallagher AG, Cates CU: Virtual reality training for the operating room and cardiac catheterisation laboratory. Lancet. 2004, 364: 1538-1540. 10.1016/S0140-6736(04)17278-4.CrossRefPubMed Gallagher AG, Cates CU: Virtual reality training for the operating room and cardiac catheterisation laboratory. Lancet. 2004, 364: 1538-1540. 10.1016/S0140-6736(04)17278-4.CrossRefPubMed
5.
go back to reference Salustri A, Roelandt JR: Three-dimensional echocardiography: where we are, where we are going. Ital Heart J. 2000, 1: 26-32.PubMed Salustri A, Roelandt JR: Three-dimensional echocardiography: where we are, where we are going. Ital Heart J. 2000, 1: 26-32.PubMed
6.
go back to reference Yambe T, Yoshizawa M, Tabayashi K, Takeda H, Nitta S: Virtual percutaneous transluminal coronary angioplasty system for an educational support system. Artif Organs. 1998, 22: 710-713. 10.1046/j.1525-1594.1998.06001.x.CrossRefPubMed Yambe T, Yoshizawa M, Tabayashi K, Takeda H, Nitta S: Virtual percutaneous transluminal coronary angioplasty system for an educational support system. Artif Organs. 1998, 22: 710-713. 10.1046/j.1525-1594.1998.06001.x.CrossRefPubMed
7.
go back to reference Klein LW: Computerized patient simulation to train the next generation of interventional cardiologists: can virtual reality take the place of real life?. Catheter Cardiovasc Interv. 2000, 51: 528-10.1002/1522-726X(200012)51:4<528::AID-CCD31>3.0.CO;2-Z.CrossRefPubMed Klein LW: Computerized patient simulation to train the next generation of interventional cardiologists: can virtual reality take the place of real life?. Catheter Cardiovasc Interv. 2000, 51: 528-10.1002/1522-726X(200012)51:4<528::AID-CCD31>3.0.CO;2-Z.CrossRefPubMed
8.
go back to reference Issenberg SB, Gordon MS, Gordon DL, Safford RE, Hart IR: Simulation and new learning technologies. Med Teach. 2001, 23: 16-23. 10.1080/01421590020007324.CrossRefPubMed Issenberg SB, Gordon MS, Gordon DL, Safford RE, Hart IR: Simulation and new learning technologies. Med Teach. 2001, 23: 16-23. 10.1080/01421590020007324.CrossRefPubMed
9.
go back to reference Koning AHJ: Applications of Volume Rendering in the CAVE. Simulation and Visualization on the Grid: Paralleldatorcentrum, seventh annual Conference, Stockholm. 1999 Koning AHJ: Applications of Volume Rendering in the CAVE. Simulation and Visualization on the Grid: Paralleldatorcentrum, seventh annual Conference, Stockholm. 1999
Metadata
Title
Dynamic 3D echocardiography in virtual reality
Authors
Annemien E van den Bosch
Anton HJ Koning
Folkert J Meijboom
Jackie S McGhie
Maarten L Simoons
Peter J van der Spek
Ad JJC Bogers
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2005
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-3-37

Other articles of this Issue 1/2005

Cardiovascular Ultrasound 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine